ホーム › 頭頸部扁平上皮癌 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける頭頸部扁平上皮癌の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
被験者募集中第3相
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13マイル先
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
被験者募集中第3相
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
被験者募集中第2相
- Thomas Jefferson University Hospital, Philadelphia
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
被験者募集中第3相
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
被験者募集中第1相
- University of Pennsylvania, Philadelphia
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- University of Pennsylvania, Philadelphia
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
被験者募集中第2相
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
被験者募集中第2相
- Research Site, Philadelphia
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
被験者募集中第1相
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- Asplundh Cancer Pavilion, Willow Grove · 13マイル先
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
被験者募集中第1相
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
被験者募集中第2/3相
- Thomas Jefferson University Hospital, Philadelphia
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
被験者募集中第3相
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23マイル先
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
被験者募集中第1相
- Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- GSK Investigational Site, Philadelphia
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
被験者募集中第1相
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
被験者募集中第1相
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- Fox Chase Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
被験者募集中
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
被験者募集中第3相
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- New York City, NY39件の研究
- Nashville, TN39件の研究
- St. Louis, MO28件の研究
- Arlington, VA26件の研究
- Chicago, IL26件の研究
- Atlanta, GA24件の研究
- San Antonio, TX22件の研究
- New Haven, CT22件の研究
- Pittsburgh, PA22件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。